Sign In
Buy PEN
$319.37
+0.630 (+0.198%)
At Close: Jun 03, 2026
Penumbra (PEN) Q1 Earnings Lag Estimates, Margins Expand
11:46am, Wednesday, 08'th May 2024
Penumbra's (PEN) Thrombectomy product category shows encouraging growth trends, reflecting strong momentum in CAVT products.
Penumbra, Inc. (PEN) Q1 2024 Earnings Call Transcript
10:33pm, Tuesday, 07'th May 2024
Penumbra, Inc. (NYSE:PEN ) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Cecilia Furlong - Director of Business Development and Investor Relations Adam Elsesser - Presid
Penumbra, Inc. Reports First Quarter 2024 Financial Results
04:05pm, Tuesday, 07'th May 2024
ALAMEDA, Calif. , May 7, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the first quarter ended Marc
Don't Overlook These Top Medical Stocks as Q1 Earnings Approach
09:01pm, Monday, 06'th May 2024
Several top-rated Zacks Medical sector stocks are standing out ahead of their quarterly reports on Tuesday, May 7.
Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference
04:05pm, Wednesday, 01'st May 2024
ALAMEDA, Calif. , May 1, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the RBC Capital Markets Global Healthcare Conference on Wed
Penumbra's (PEN) New Launch to Enhance Blood Clot Removal
12:46pm, Wednesday, 24'th Apr 2024
Penumbra's (PEN) latest offering is likely to enable physicians to restore blood flow more quickly and further minimize blood loss.
GMED vs. PEN: Which Stock Is the Better Value Option?
12:41pm, Tuesday, 23'rd Apr 2024
Investors with an interest in Medical - Instruments stocks have likely encountered both Globus Medical (GMED) and Penumbra (PEN). But which of these two companies is the best option for those looking
Here's Why Penumbra (PEN) is a Strong Growth Stock
10:46am, Tuesday, 23'rd Apr 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots
09:00am, Tuesday, 23'rd Apr 2024
Lightning Flash™ 2.0 features advanced computer assisted vacuum thrombectomy (CAVT) software, designed for increased efficiency and sensitivity to enhance removal of venous thrombus and treatment o
Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
04:05pm, Tuesday, 09'th Apr 2024
ALAMEDA, Calif. , April 9, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2024 after market clos
Here's Why You Should Retain Penumbra (PEN) Stock for Now
10:35am, Monday, 08'th Apr 2024
Investors are optimistic about Penumbra (PEN) on strength exhibited in the Thrombectomy business and global expansion.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:56am, Wednesday, 03'rd Apr 2024
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Penumbra (PEN) Gains From Innovation, Mounting Costs Ail
10:51am, Tuesday, 05'th Mar 2024
Penumbra (PEN) expects to materially increase both revenues and profitability in the company's international business in the next three years and beyond.
Why Penumbra (PEN) is a Top Growth Stock for the Long-Term
10:46am, Tuesday, 27'th Feb 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Penumbra (PEN) Q4 Earnings Top Estimates, Margins Increase
12:46pm, Monday, 26'th Feb 2024
Penumbra's (PEN) Q4 revenues register year-over-year growth driven by robust U.S. thrombectomy sales.
